Targeted delivery of liposomal senolytics to alleviate cellular senescence-induced bone loss.

Summary: When people receive treatments like chemotherapy or radiation for cancer, their bones can become weak and brittle. This happens because "zombie cells"—old cells that stop working but refuse to die—build up inside the bone. Scientists have found a way to clear out these zombie cells using a combination of two medicines: dasatinib and quercetin.

Because these medicines are hard for the body to absorb by mouth, researchers packed them into tiny fat bubbles called liposomes. They even added a special bone-seeking tool to the outside of these bubbles so the medicine travels straight to the bones! In mice, this new treatment worked amazingly well. It cleared out the bad cells and more than doubled the bone thickness, offering a highly promising new way to fix bone damage caused by cancer treatments.